Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 71335-1783

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 71335-1783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula 1 (Image 01)

Chemical structure of the active ingredients Lisinopril and Hydrochlorothiazide as depicted by the molecular diagram showing their atomic arrangement and bonding.*

FDA Label Image

Structural Formula 2 (Image 02)

Chemical structure of Lisinopril and Hydrochlorothiazide, showing a chlorobenzene ring with sulfonamide groups and associated functional groups, consistent with the active ingredients in the medication.*

FDA Label Image

Label (Lbl713351783)

Label for Lisinopril and Hydrochlorothiazide 20/25 mg tablet, a human prescription oral tablet packaged by Bryant Ranch Prepack. The label notes the product is pink (peach), round, and compares to Zestoretic 20/25 mg tablets by InvaGen Pharmaceuticals. It includes storage instructions to keep tightly closed and store at room temperature 20°-25°C (68°-77°F). The package count is 30 tablets, and the NDC is 71335-1783.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.